Avacta Group plc (AIM: AVCT), a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative Affimer® and pre|CISION™ platforms, announces the appointment of Dr Mark Goldberg as Non-executive Director to the Board with immediate effect.
Zyme Communications provides PR and marketing services for the life science sector. We support companies to raise their profile, build corporate value and generate interest from commercial leads, investors and partners.
Telephone: +44 (0)1223 968 920
Stirling House, Cambridge Innovation Park, Denny End Road, Waterbeach, Cambridge
Post Code: CB25 9QE
Country: United Kingdom
Membership Type: Corporate 6-20